Infectious Disease · PANCE / PANRE

Erythema Infectiosum (Fifth Disease, Parvovirus B19)

'Slapped cheek' facial rash followed by lacy reticular truncal rash in school-age children; risks include aplastic crisis in hemolytic anemias and hydrops fetalis in pregnancy.

Also known as: fifth disease, 5th disease, parvovirus B19, slapped cheek syndrome, erythema infectiosum

Overview

Common childhood viral exanthem caused by parvovirus B19, a single-stranded DNA virus that targets erythroid progenitors via the P antigen (globoside) receptor. The classic 'slapped cheek' rash heralds resolving viremia; arthropathy is common in adults.

Epidemiology

Worldwide; outbreaks in late winter and spring in school-age children. By age 15, ~50% are seropositive. Transmission via respiratory droplets and blood products. Infectious BEFORE the rash appears — patients are no longer contagious by the time the rash is recognized.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Erythema Infectiosum (Fifth Disease, Parvovirus B19) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • School and daycare exposure
  • Pregnancy without prior immunity (highest risk weeks 13-20 for hydrops fetalis)
  • Chronic hemolytic anemia (sickle cell, hereditary spherocytosis, thalassemia) — risk of transient aplastic crisis
  • Immunocompromise (pure red cell aplasia and chronic anemia)

Pathophysiology

Virus binds the P antigen (globoside) on erythroid progenitors, halting erythropoiesis and producing transient reticulocytopenia. The classic exanthem is immune-complex-mediated and appears as viremia resolves, explaining lack of contagiousness when the rash is visible.

Clinical presentation

Symptoms

  • Mild prodrome with low-grade fever, headache, coryza 5-7 days earlier (often missed)
  • Stage 1 — bright erythematous 'slapped cheek' rash with circumoral pallor
  • Stage 2 — lacy, reticular maculopapular rash on extensor surfaces of arms, then trunk and legs, lasting 1-3 weeks; recurs with sun, heat, exercise
  • Adults: arthralgias and symmetric polyarthritis of hands, wrists, knees, ankles; rash often subtle or absent

Signs / physical exam

  • Slapped-cheek facies
  • Lacy/reticular rash that waxes and wanes with temperature and sunlight
  • Symmetric small-joint synovitis without joint destruction
  • Pallor or jaundice in patients with aplastic crisis

Classic findings

Bright red 'slapped cheeks' with circumoral pallor in a school-age child.

Differential diagnosis

  • Rubella — Posterior auricular nodes, head-to-toe rash, vaccine history
  • Measles — Three Cs, Koplik spots, cephalocaudal rash
  • Roseola — Younger child, high fever resolves as rash appears
  • Drug eruption — Recent new medication; no facial slapped-cheek pattern
  • Systemic lupus / juvenile dermatomyositis — Persistent malar rash with systemic features
  • Scarlet fever — Sandpaper rash, strep throat, Pastia lines

Diagnostic workup

Diagnostic criteria

Clinical syndrome supported by IgM positivity or PCR (in atypical/high-risk hosts).

Labs

  • Clinical diagnosis in immunocompetent children with classic rash
  • Parvovirus B19 IgM (acute), IgG (immunity) — preferred in pregnancy and adult arthralgia
  • Parvovirus B19 DNA PCR for immunocompromised, fetal, and aplastic crisis cases
  • CBC with reticulocyte count in patients with hemolytic anemia — low reticulocytes during aplastic crisis

Imaging

  • Fetal ultrasound (every 1-2 weeks for 8-12 weeks after maternal exposure) — measure middle cerebral artery peak systolic velocity for fetal anemia
  • MCA-PSV >1.5 MoM suggests fetal anemia and prompts referral for possible intrauterine transfusion

Treatment

First-line

  • Supportive care: antipyretics, antihistamines for pruritus
  • No isolation needed once rash appears (patient is no longer infectious)
  • NSAIDs for adult arthralgias (self-limited, no joint destruction)

Transient aplastic crisis (sickle cell, hemolytic anemias)

  • Hospitalize, monitor hemoglobin, transfuse PRBCs as needed
  • Droplet and contact isolation (these patients ARE still contagious because viremia persists)

Pregnancy exposure

  • Check maternal IgG/IgM
  • If seroconverts, serial ultrasound with MCA Doppler
  • Refer to maternal-fetal medicine if hydrops fetalis suspected; intrauterine transfusion may be life-saving

Immunocompromised (chronic anemia/pure red cell aplasia)

  • IVIG (parvovirus B19 has no specific antiviral) — clears persistent viremia in many
  • Reduce immunosuppression if feasible

Second-line / adjunct

  • Reassure pregnant patients: most exposures do NOT result in hydrops fetalis; baseline fetal loss risk <5% overall

Complications

  • Transient aplastic crisis in hemolytic anemia
  • Pure red cell aplasia in immunocompromised hosts (HIV, post-transplant)
  • Hydrops fetalis and fetal loss (highest risk weeks 13-20)
  • Adult symmetric polyarthropathy (transient, no destruction)
  • Rare: myocarditis, glomerulonephritis, hepatitis, encephalopathy

PANCE pearls

  • Rash appears AFTER contagiousness has ended — no isolation needed for typical erythema infectiosum.
  • Sickle cell + parvovirus = transient aplastic crisis; these patients ARE still contagious and need isolation.
  • Pregnancy exposure before 20 weeks → check IgM/IgG and arrange MCA Doppler surveillance.
  • Adults more often present with symmetric polyarthropathy than rash — consider parvovirus in seronegative adult inflammatory arthritis.
  • IVIG is the treatment for parvovirus B19 in the immunocompromised — there is no antiviral.

References

  • AAP Red Book — American Academy of Pediatrics Red Book — Parvovirus B19 chapter
  • ACOG — ACOG Practice Bulletin — Management of Pregnancy Complicated by Parvovirus B19 Exposure
  • CDC — CDC Clinical Overview of Parvovirus B19

Practice Infectious Disease questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.